RAPT
RAPT Therapeutics Inc
NASDAQ: RAPT · HEALTHCARE · BIOTECHNOLOGY
$58.02
+0.00% today
Updated 2026-03-04
Market cap
$1.68B
P/E ratio
—
P/S ratio
411.22x
EPS (TTM)
$-11.66
Dividend yield
—
52W range
$6 – $58
Volume
3.2M
RAPT Therapeutics Inc (RAPT) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
-139.7%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
-37.2%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+2.1%
Last 1 reports
Positive reaction rate
100%
1 of 1 quarters
Largest single-day move
+2.1%
2025-11-06
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2025-11-06 | $-0.65 | -499.1% | $28.27 | $28.86 | +2.1% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-09-30 | $-0.11 | $-0.65 | -499.1% | — | — |
| 2025-06-30 | $-0.09 | $-0.65 | -622.2% | — | — |
| 2025-03-31 | $-0.14 | $-0.08 | +41.2% | — | — |
| 2024-12-31 | $-0.36 | $-1.22 | -243.6% | — | — |
| 2024-09-30 | $-0.56 | $-0.47 | +15.4% | — | — |
| 2024-06-30 | $-0.72 | $-0.71 | +1.4% | — | — |
| 2024-03-31 | $-0.81 | $-0.79 | +2.5% | — | — |
| 2023-12-31 | $-0.86 | $-0.80 | +7.0% | $5.29M | +725.0% |
| 2023-09-30 | $-0.75 | $-0.82 | -9.3% | — | — |
| 2023-06-30 | $-0.78 | $-0.66 | +15.4% | — | — |
| 2023-03-31 | $-0.68 | $-0.76 | -11.8% | — | — |
| 2022-12-31 | $-0.65 | $-0.64 | +1.5% | $641000.00 | — |
Frequently asked questions
Has RAPT Therapeutics Inc beaten earnings estimates?
RAPT Therapeutics Inc has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of -139.7% over the last 4 quarters.
How does RAPT stock react to earnings?
RAPT stock has moved an average of +2.1% in the trading day following earnings over its last 1 reports, with positive reactions in 100% of those quarters.